Mirta Dumancić

Mirta Dumancić is a prominent inventor based in Beer Sheva, Israel. She has made significant contributions to the field of radiation therapy, particularly in the treatment of various types of tumors. With a total of 8 patents to her name, Dumancić is recognized for her innovative approaches to cancer treatment.

Latest Patents

Among her latest patents, Dumancić has developed methods for diffusing alpha-emitter radiation therapy for colorectal cancer and glioblastoma. The colorectal cancer treatment involves identifying a tumor as a colorectal cancer tumor and implanting a diffusing alpha-emitter radiation therapy (DaRT) source with a specific radon release rate. This method ensures that the source provides a cumulated activity of released radon between 3.7 Mega becquerel (MBq) hour and 9.2 MBq hour, per centimeter length during the treatment duration. Similarly, her glioblastoma treatment method also utilizes a DaRT source, with a radon release rate that provides a cumulated activity between 6.5 Mega becquerel (MBq) hour and 14.3 MBq hour, per centimeter length.

Career Highlights

Dumancić is currently associated with Alpha Tau Medical Ltd., where she continues to advance her research and development in radiation therapy. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from aggressive forms of cancer.

Collaborations

Throughout her career, Dumancić has collaborated with notable colleagues such as Itzhak Kelson and Yona Keisari. These partnerships have contributed to the success and innovation of her projects.

Conclusion

Mirta Dumancić stands out as a leading inventor in the field of radiation therapy, with her groundbreaking patents paving the way for new treatment options for cancer patients. Her dedication to innovation continues to inspire advancements in medical technology.